Skip to content
+44 1865 248455
info@oxfordglobal.co.uk
Enquire
Twitter
Linkedin-in
Discovery US 2024
: Speakers
Speakers
November 2024 | Boston, USA
Part of the
Discovery Series
Organ Modelling and
3D Cell Culture 2024
Discovery Europe
2024
Automate Europe
2024
Discovery US
2024
Home
Agenda
Speakers
Sponsorship
Attendees
Media Partners
PLUS Pass
Menu
Home
Agenda
Speakers
Sponsorship
Attendees
Media Partners
PLUS Pass
Book Now
Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.
The following were confirmed speakers for Discovery US 2023
Aaron Frank
Director and Head of Computational Chemistry
Arrakis Therapeutics
Abhinav Sharma
Translational Human Models Lead Engineer, Discovery Immunology
AbbVie
Amir Nikooie
Director
Eli Lilly and Company
Andrew Doran
Principal Scientist
Anagenex
Angel Guzman-Perez
Head of Chemistry
Scorpion Therapeutics
BanuPriya Sridharan
Associate Director
GSK
Beth Hoffman
Chief Executive Officer
Origami Therapeutics Inc.
Dane Corneil
Director
Benevolent AI
Dave Mauger
Director and Head of Data Science
Arrakis Therapeutics
Elliott Nickbarg
Principal Scientist
Merck
Eric Martin
Director
Novartis
Eric Miele
Associate Director
AstraZeneca
Esther Lee
Associate Director
AstraZeneca
Glenn Kazo
Chief Business Officer
ARIZ Precision Medicine
Govinda Bhisetti
Vice President
Cellarity
Hasan Khan
Senior Scientist
AbbVie
Hongwu Wang
Principal Scientist
Merck
Istvan Enyedy
Senior Principal Scientist
UCB
James Hickman
Professor
University of Central Florida
Jason Ekert
Head of US Discovery Translational Technology
UCB
Jeannie Lee
Professor of Genetics
Harvard Medical School
Jeff Messer
Director
GSK
Joe Franklin
Senior Vice President
Anagenex
John Quinn
Distinguished Scientist, Biochemical and Cellular Pharmacology
Genentech
John Santa Maria
Associate Director
Fog Pharmaceuticals
Justyna Skikorska
Principal Scientist
Merck
Kevin Robbins
Associate Principal Scientist
AstaZeneca
Lauren Goodrich
Vice President
Nimble Therapeutics
Mark Murcko
Director
Dewpoint Therapeutics
Martin Redhead
Executive Director
Excientia
Matthew Pharris
Senior Scientist
UCB
Maximilian Schuier
Senior Global Medical Affairs Leader
Janssen
Michael Schopperle
Chief Executive Officer
CureMeta
Nils Jakob Hansen
Chief Executive Officer
Vipergen ApS
Paul Scola
Group Director
Bristol Myers Squibb
Rajeswari Basu
Research Scientist
Boehringer Ingelheim
Ralph Mazitschek
Investigator
Harvard Medical School
Shahar Keinan
Chief Executive Officer
POLARISqb
Shaun McLoughlin
Principal Research Scientist
AbbVie
Sina Mohammadi
Principal Scientist
Merck
Stefan Peukert
Associate Director
Novartis
Suresh Kumar
Vice President R&D
Progenra
Thomas Hartung
Professor
John Hopkins Bloomberg School of Public Health
Thomas Nittoli
Senior Director
Regeneron Pharmaceuticals
Tobias Raabe
Research Assistant Professor
University of Pennsylvania
Tomek Cierpicki
Professor
University of Michigan
Xiang Chen
Senior Research Scientist
St Jude Children's Research Hospital
Yuan Wang
Head of Research Analytics
UCB
Yuxin Liang
Principal Scientific Manager
Genentech